Flat Topline, Unfavourable Product Mix Results in Gross Margin Decline over Next 3-5 Years
We reiterate our âEqual-weightâ rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings.Kissei Pharmaceutical Co Ltd (4547...
379 Views
Kissei FY17 Earnings - First Glance
Kissei Pharmaceutical Co Ltd (4547 JP) reported FY17 results on May 09, 2018 Urief and P-Tol driven FY17 top-line growth in line with...
124 Views